ORMP:NASDAQ
Oramed Pharmaceuticals, Inc.
$4.13
arrow_upward
+0.24%(+0.010) 1D
Oct 23, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORMP...
Open
$4.10
High
$4.17
Low
$4.06
Mkt. cap
171.80M
Avg. vol.
163.99K
Volume
115.66K
P/E ratio
1.00
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
Open
$4.10
High
$4.17
Low
$4.06
Mkt. cap
171.80M
Avg. vol.
163.99K
Volume
115.66K
P/E ratio
1.00
52-wk high
$5.47
52-wk low
$2.09
EPS
$4.13
Beta
1.29
Shares outstanding
41.60M
No. of employees
13
News stories
From web sources and news partners
Around Prague
·
20 hours ago
What Oil Near $117 and a Dow Slide Mean for Gas, Mortgages and Prices
UA.NEWS
·
20 hours ago
Dow Jones falls 1.2% amid concerns over AI spending — The Rio Times
BigGo Finance
·
4 hours ago
Dow Plunges 652 Points After Crude Oil Tops $100 on Renewed US-Iran War Fears
Reuters Connect
·
2 days ago
Licensable video: S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
Profile
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange. Wikipedia
About Oramed Pharmaceuticals, Inc.